Post by
baggerx99 on Aug 23, 2021 11:22am
Could ATE see a similar headline?
Pfizer Inc. said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal.
Comment by
Yellowknifer69 on Aug 23, 2021 11:40am
not this year - maybe once they prove out 346. Yellowknifer
Comment by
nozzpack on Aug 23, 2021 6:16pm
Just goes to show how innovative and unique medical solutions are in demand. Almost certainly ATB 346 et al qualifies as innovative and unique. And, shown to exceed the therapeutic benfits relative to disbenefits of its major competitors which have a near $trillion share of pain mitigation drugs.